Beyond Air, Inc. Files 8-K: Board Changes & Officer Compensation
Ticker: XAIR · Form: 8-K · Filed: Dec 11, 2025 · CIK: 1641631
| Field | Detail |
|---|---|
| Company | Beyond Air, Inc. (XAIR) |
| Form Type | 8-K |
| Filed Date | Dec 11, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $260,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, officer-compensation, corporate-governance
TL;DR
Beyond Air board shakeup and new officer pay details filed. 8-K dropped.
AI Summary
Beyond Air, Inc. announced on December 8, 2025, a change in its board of directors, with the election of new directors and the appointment of certain officers. The company also reported on compensatory arrangements for its officers. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
Changes in a company's board and officer compensation can signal shifts in strategy, governance, or financial priorities that may impact investors.
Risk Assessment
Risk Level: medium — Filings related to board composition and executive compensation can indicate internal changes that may carry strategic or financial risks.
Key Players & Entities
- Beyond Air, Inc. (company) — Registrant
- December 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 47-3812456 (ein) — I.R.S. Employer Identification No.
- 900 Stewart Avenue, Suite 301 (address) — Business Address
- Garden City (city) — Business Address City
- NY (state) — Business Address State
- 11530 (zip_code) — Business Address Zip
- AIT Therapeutics, Inc. (company) — Former Company Name
- 20170117 (date) — Date of Former Company Name Change
FAQ
What specific changes were made to the board of directors of Beyond Air, Inc. on December 8, 2025?
The filing indicates the election of new directors and the appointment of certain officers, but the specific names and details of these changes are not provided in the excerpt.
What is the nature of the compensatory arrangements for certain officers that are being reported?
The filing states that information regarding compensatory arrangements of certain officers is being reported, but the specific details of these arrangements are not included in the provided text.
What is the primary purpose of this Form 8-K filing for Beyond Air, Inc.?
This Form 8-K is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on the departure of directors, election of directors, appointment of officers, and compensatory arrangements.
When was Beyond Air, Inc. incorporated, and in which state?
Beyond Air, Inc. was incorporated in Delaware.
What are the former names of Beyond Air, Inc. and when did these name changes occur?
Beyond Air, Inc. was formerly known as AIT Therapeutics, Inc. (name change on January 17, 2017) and KokiCare, Inc. (name change on May 7, 2015).
Filing Stats: 594 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-12-11 17:16:33
Key Financial Figures
- $260,000 — eceive his current base compensation of $260,000 per year and to participate in the Comp
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-25-027289.txt ( ) — 200KB
- xair-20251208.xsd (EX-101.SCH) — 3KB
- xair-20251208_lab.xml (EX-101.LAB) — 33KB
- xair-20251208_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEYOND AIR, Inc. Date: December 11, 2025 By: /s/ Steven A. Lisi Name: Steven A. Lisi Title Chief Executive Officer